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Immune escape contributes to viral persistence, yet little is known about human
polyomaviruses. BK-polyomavirus (BKPyV) asymptomatically infects 90% of hu-
mans but causes premature allograft failure in kidney transplant patients. Despite
virus-specific T cells and neutralizing antibodies, BKPyV persists in kidneys and
evades immune control as evidenced by urinary shedding in immunocompetent
individuals. Here, we report that BKPyV disrupts the mitochondrial network
and membrane potential when expressing the 66aa-long agnoprotein during
late replication. Agnoprotein is necessary and sufficient, using its amino-terminal
and central domain for mitochondrial targeting and network disruption, respec-
tively. Agnoprotein impairs nuclear IRF3-translocation, interferon-beta expres-
sion, and promotes p62/SQSTM1-mitophagy. Agnoprotein-mutant viruses
unable to disrupt mitochondria show reduced replication and increased
interferon-beta expression but can be rescued by type-I interferon blockade,
TBK1-inhibition, or CoCl2-treatment. Mitochondrial fragmentation and p62/
SQSTM1-autophagy occur in allograft biopsies of kidney transplant patients
with BKPyV nephropathy. JCPyV and SV40 infection similarly disrupt mitochon-
drial networks, indicating a conserved mechanism facilitating polyomavirus
persistence and post-transplant disease.
INTRODUCTION
Viruses infect all forms of life, and although metagenomics are revealing an increasing complexity of vi-
romes (Hirsch, 2019; Simmonds et al., 2017; Virgin, 2014), the underlying principle remains the same: viral
genetic information present as DNA or RNA is decoded by host cells, thereby enabling a programmed
take-over of cell metabolism to accomplish the essential steps of viral genome replication, packaging,
and progeny release to infect new susceptible cells and hosts (Enquist and Racaniello, 2013). With progeny
rates ranging from ten to several hundred-thousands per cell, virus replication represents a severe burden
compromising host cell function and viability and ultimately organ and host integrity. Host defense mech-
anisms include antiviral restriction factors (Kluge et al., 2015) as well as innate and adaptive immune re-
sponses (McNab et al., 2015) intercepting early and late steps of the viral life cycle. Given the obligatory
intracellular location of virus replication, the innate immune response is faced with the challenge of discrim-
inating virus and its regulatory and structural units as ‘‘non-self’’ amid physiological host cell constituents.
This task is partly accomplished by identifying pathogen-associated molecular patterns (PAMPs) such as
repetitive protein, lipid, and sugar structures through pattern recognition receptors (PRRs). In the last
decade, cytoplasmic sensing of nucleic acids has emerged as a key mechanism of intracellular innate im-
mune sensing (Takeuchi and Akira, 2010). Evolutionarily linked to detecting DNA damage and the failing
integrity of nuclei or mitochondria associated with metabolic stress, toxicity, or cancer (Hartlova et al.,
2015; Li and Chen, 2018; West and Shadel, 2017), viral RNA and DNA were found to be similarly sensed
through PRRs such as RIG-I/MDA-5/MAVS and cGAS/STING (Goubau et al., 2013; Hartlova et al., 2015;
McFadden et al., 2017). MAVS and STING have been located on membranous platforms of mitochondria
and the endoplasmic reticulum (ER) in the cytosol. Besides direct cross-talk (Zevini et al., 2017) and prox-
imity via mitochondria-associated ER-membranes (MEM), both pathways converge in inducing type-1
interferon expression following the activation of the downstream kinases TBK-1 and IKKε and theiScience 23, 101257, July 24, 2020 ª 2020 The Author(s).





Articlephosphorylation and nuclear translocation of transcription factors such as IRF3, IRF7, and NFkB (Liu et al.,
2015; McFadden et al., 2017). Interferons are key mediators of the antiviral state in infected and neigh-
boring cells and help to activate the adaptive antigen-specific immune responses (Iwasaki and Medzhitov,
2010; Schneider et al., 2014). Different molecular mechanisms of innate immune activation are induced in
acute and chronic infections with human RNA or DNA viruses, and a variety of strategies has been
described, which may permit transient or persistent viral evasion (Garcia-Sastre, 2017). However, such as-
pects are incompletely understood for small non-enveloped DNA viruses such as human polyomaviruses.
BK polyomavirus (BKPyV) is one of more than 10 human polyomaviruses and infects >90% of the general
population typically during childhood without specific illness (Greenlee and Hirsch, 2017; DeCaprio
et al., 2013). Although BKPyV induces potent virus-specific CD4 and CD8 T cells (Binggeli et al., 2007;
Chen et al., 2008; Cioni et al., 2016; Leboeuf et al., 2017) and neutralizing antibodies (Kaur et al., 2019; Pas-
trana et al., 2012; Shah et al., 1980; Solis et al., 2018), the virus latently persists in the kidneys and regularly
escapes from immune control as evidenced by asymptomatic urinary virus shedding in immunocompetent
healthy individuals (Egli et al., 2009; Imperiale and Jiang, 2016). In immunosuppressed patients, BKPyV
replication increases in rate and magnitude, progressing to hemorrhagic cystitis and nephropathy in
5%–25% and 1%–15% of allogeneic bone marrow transplant and kidney transplant recipients, respectively,
and even urothelial cancer (Cesaro et al., 2018; Graf and Hirsch, 2020; Hirsch and Randhawa, 2019). Because
specific antiviral agents and vaccines are not available, reducing immunosuppression is the current main-
stay of therapy in order to regain control over BKPyV replication (Cesaro et al., 2018; Hirsch and Randhawa,
2019). However, this maneuver increases the risk of immunological injury such as allograft rejection or graft-
versus-host disease. In our ongoing study to identify functionally and diagnostically relevant targets of
BKPyV-specific antibody and T cell responses (Binggeli et al., 2007; Cioni et al., 2016; Leboeuf et al.,
2017), we noted that the small BKPyV agnoprotein of 66 amino acids (aa) is abundantly expressed in the
cytoplasm during the late viral life cycle in vitro and in vivo but largely ignored by the adaptive immunity
(Leuenberger et al., 2007; Rinaldo et al., 1998). BKPyV agnoprotein co-localizes with lipid droplets (LD)
(Unterstab et al., 2010) and membranous structures of the ER (Unterstab et al., 2013). We now report
that the BKPyV agnoprotein also targets mitochondria and subverts interferon-b induction by disrupting
the mitochondrial network and its membrane potential and promotes p62/SQSTM1 mitophagy in cell
culture and in kidney allograft biopsies.RESULTS
BKPyV Agnoprotein Colocalizes with Mitochondria and Induces Mitochondrial
Fragmentation
To elucidate the function of BKPyV agnoprotein in the absence of LD, we noted that the N-terminal amino
acid (aa) sequence had similarity tomitochondrial targeting sequence (MTS) found in cytochrome c oxidase
cox8 (Figure S1). To investigate the potential mitochondrial localization, we infected primary human renal
proximal tubular epithelial cells (RPTECs) with the agnoprotein wild-type BKPyV-Dunlop (Dun-AGN), a
well-characterized model of renal allograft nephropathy (Bernhoff et al., 2008; Hirsch et al., 2016; Low
et al., 2004). The results were compared with the isogenic derivative Dun-agn25D39E, of which the en-
coded point mutant agnoprotein is known to no longer bind to LD after replacing the hydrophobic A25
and F39 with D and E, respectively, abrogating the amphipathic character of the central agnoprotein
domain without affecting the a-helix prediction (Unterstab et al., 2010).
At 48-h post-infection (hpi) with wild-type Dun-AGN and mutant Dun-agn25D39E viruses, immunofluores-
cent staining identified infected cells in the late viral replication phase by detecting both the early viral
protein large T-antigen (LTag) and the late viral protein Vp1 capsid in the nucleus and agnoprotein in
the cytoplasm (Figure S2). Using the mitochondrial outer membrane protein Tom20 as a marker, its specific
colocalization with both the AGN wild-type and agn25D39Emutant protein was found, demonstrating ag-
noprotein colocalization to mitochondria (Figure 1A). However, the mitochondria of Dun-AGN-replicating
RPTECs had lost the network-like pattern typical of uninfected cells and appeared in short, fragmented
units (Figure 1A, Video S1). In contrast, Dun-agn25D39E-replicating RPTECs exhibited a regular mitochon-
drial network similar to neighboring uninfected cells (Figure 1A; Video S2). Quantification of the mitochon-
drial morphology indicated a large excess of short mitochondrial fragments in Dun-AGN-infected cells,
whereas mostly elongated mitochondria in a network-like pattern were seen in the Dun-agn25D39E-in-
fected cells (Figure 1B). Given these striking differences in mitochondrial phenotype, we examined whether
or not the mutant agn25D39E-agnoprotein was still able to target the ER as reported for the wild-type2 iScience 23, 101257, July 24, 2020
Figure 1. Agnoprotein Colocalizes with Mitochondria and Induces Mitochondrial Fragmentation in the Late
Replication Phase of BKPyV Infection
(A) Z-stacks of RPTECs infected with BKPyV Dun-AGN (top row) or with Dun-agn25D39E (bottom row, large replicating cell
next to small non-replicating cell) at 48 hpi, stained for Tom20 (red), agnoprotein (green), and DNA (blue). Colocalizing
voxels are shown in yellow.
(B) Quantification of mitochondrial morphology in six fields of two independent experiments using Fiji software (mean G
SD, two-way ANOVA).
(C) Z-stacks of BKPyV Dun-agn25D39E-infected cells at 48 hpi, stained for mitochondrial marker Tom20 (red), calreticulin
as marker for the ER(magenta), agnoprotein (green), and DNA (blue). Colocalizing voxels are shown in yellow (scale bar,
5 mm).
(D) Confocal images of RPTECs infected with BKPyV Dun-AGN at indicated times post-infection. Cells were stained for
LTag (red), agnoprotein (green), mitochondrial marker Tom20 (cyan), and DNA (blue). White arrows indicate cells




Articleagnoprotein (Unterstab et al., 2013). Confocal microscopy revealed that the agn25D39E protein colocal-
ized with the ER marker calreticulin (Figure 1C). However, whereas the mitochondrial colocalization of
the agn25D39E protein appeared in network strings, the ER colocalization with calreticulin was patchy
and reminiscent of the contact sites with the mitochondria-associated membranes (MEMs) (Figure 1C).
The patchy ER-colocalization pattern was independently confirmed using protein disulphide isomerase




Articleremained intact and implicated the amphipathic character of the central a-helix of the wild-type agnopro-
tein in the disruption of the mitochondrial network.
To correlate the severely altered mitochondrial morphology with the viral life cycle, we examined a time
course of Dun-AGN infection demonstrating that expression of the early viral LTag at 24 hpi had no effect
on the mitochondrial network (Figure 1D). After 36 hpi, expression of the late viral gene region had started
and agnoprotein appeared in the cytoplasm, but mitochondrial fragmentation and perinuclear condensa-
tion became apparent only from 48 hpi onwards. At 72 hpi, Dun-AGN-replicating cells could be readily
identified solely by the dramatically fragmented mitochondrial network using Tom20 staining (Figure 1D).
Thus, wild-type and agn25D39E agnoprotein were able to localize to both mitochondria and the ER, which
in case of the wild-type Dun-AGN led to mitochondrial fragmentation, whereas this was not observed for
the Dun-agn25D39E mutant.
To further characterize the role of agnoprotein and its amphipathic helix in BKPyV replication, two addi-
tional isogenic derivatives were generated: Dun-agn25L39L encoding a mutant agnoprotein retaining
the amphipathic character of the central a-helix, and Dun-ATCagn, in which the ATG start codon had
been changed to ATC to create a ‘‘null’’-agnoprotein virus. Ribbon models predicted that the overall
secondary structures of agn25D39E and agn25L39L were similar to the AGN-encoded wild-type protein
in having a short N-terminal and a central helix, whereas the C-terminal structure was not predictable
except for a short terminal a-helical tail (Figure 2A). All BKPyV variants were found to proceed to expression
of the late viral gene region, as evidenced by nuclear Vp1 staining (Figure 2B). Similar to Dun-AGN wild-
type infection, the Dun-agn25L39L-infected RPTECs exhibited a cytoplasmic agnoprotein distribution
and mitochondrial fragmentation (Figure 2B). In contrast, Dun-ATCagn-infected RPTECs retained intact
mitochondrial networks similar to Dun-agn25D39E but lacked agnoprotein expression as expected (Fig-
ure 2B). Because LD-binding had been shown to require the amphipathic character of the central a-helix
(Figure 2A) now implicated in mediating mitochondrial fragmentation (Unterstab et al., 2010), the effect
of LD-formation on the mitochondrial network was investigated. To this end, RPTECs were infected with
Dun-AGN or with Dun-agn25D39E, and 300 mM oleate was added at 24 hpi after early viral gene region
expression. Confocal microscopy of Dun-AGN at 48 hpi revealed that agnoprotein was sequestered
around LD as described previously, but mitochondrial fragmentation of Dun-AGN infected cells was
prevented (Figure 2C). In contrast, Dun-agn25D39E-infected RPTECs retained the mitochondrial colocal-
ization of the mutant agnoprotein without sequestering to LD (Figure 2C, magnification panel bottom
right), which in the absence of LD staining are known to appear as punched-out holes (Unterstab et al.,
2010). These results linked the amphipathic helix of agnoprotein to LD binding and to mitochondrial frag-
mentation in a competitive manner.
To investigate the functional consequences of agnoprotein expression, we examined the mitochondrial
membrane potential (MMP) using the (Jm)-dependent accumulation of JC-1 dye, whereby mitochondrial
depolarization is indicated by a decrease in the red/green fluorescence intensity. At 48 hpi, Dun-AGN-in-
fected cells exhibited fragmented mitochondria (green channel) and a significant decrease in MMP (red
channel), whereas MMP changed little in Dun-agn25D39E- or Dun-ATCagn-infected RPTECs or in mock-
treated cells (Figure 2D). Similarly, automated measurements of overall JC-1 red and green signals in
cell culture revealed significant MMP decreases of about 40% in Dun-AGN-infected RPTECs at 48 hpi
compared with controls. Together, the results indicated that infection with BKPyV expressing an agnopro-
tein with a central amphipathic helix was necessary for MMP breakdown and network fragmentation in the
late viral replication phase.Agnoprotein Is Sufficient for Mitochondrial Fragmentation and Breakdown of the
Mitochondrial Membrane Potential and Impairs Innate Immune Signaling
To investigate whether or not agnoprotein expression alone is sufficient for mitochondrial fragmentation,
expression vectors containing the full-length gene of wild-type agnoprotein or agnoprotein subdomains
fused to monomeric enhanced green fluorescent protein (mEGFP) (Unterstab et al., 2010) were transfected
into UTA6 cells (Figure 3A). At 24 h post-transfection (hpt) of the agno(1-66)mEGFP construct, GFP and ag-
noprotein overlapped in their colocalization to fragmented mitochondria (Figure 3A, top row). Similarly,
mitochondrial colocalization and fragmentation was seen for agno(1-53)mEGFP lacking the C-terminal
13 aa of agnoprotein, but not for any of the other truncated agnoprotein constructs shown. Because the
truncated agno(20-66)mEGFP had been previously demonstrated to be able to still colocalize with LD4 iScience 23, 101257, July 24, 2020
Figure 2. The Amphipathic Character of the Central Agnoprotein Helix Is Required for Mitochondrial
Fragmentation
(A) Three-dimensional ribbon model of each agnoprotein derivate as predicted with the Quark online algorithm (https://
zhanglab.ccmb.med.umich.edu/I-TASSER/) and predicted amphipathic helical wheel of the agnoprotein amino acids 22–
39 (http://cti.itc.virginia.edu/cmg/Demo/wheel/wheelApp.html).
(B) Confocal images of RPTEC-infected with BKPyV Dun-AGN and isogenic derivatives Dun-agn25D39E, Dun-agn25L39L,
and Dun-ATCagn, respectively. Cells were fixed at 48 hpi and stained for mitochondrial marker Tom20 (red), agnoprotein
(green), Vp1 (cyan), and DNA (blue) (scale bar, 20 mm).
(C) Confocal images of RPTECs infected with BKPyV Dun-AGN and BKPyV-Dun-agn25D39E, respectively, at 48 hpi. Cells
were mock-treated or treated with 300 mM oleate at 24 hpi (plus oleate). Cells were stained for Tom20 (red), agnoprotein
(green), and DNA (blue) (scale bar, 20 mm).
(D) Live cell imaging using JC-1 dye (5 mM) of mock-infected or infected with BKPyV Dun-AGN and isogenic derivatives
Dun-agn25D39E, Dun-agn25L39L, and Dun-ATCagn, respectively at 48 hpi. Quantification of mitochondrial membrane
potential (Jm) by measuring red fluorescent signal (JC-1 aggregates) with the Safire II plate reader of three independent




Article(Unterstab et al., 2010), we hypothesized that the N-terminal domain was necessary for mitochondrial tar-
geting in order to mediate the breakdown of the mitochondrial network. Therefore, the N-terminal mito-
chondrial targeting sequence of cytochrome c oxidase (MTScox8) was fused to agno(20-66)mEGFP
yielding MTScox8-agno(20-66)mEGFP (Figure S1). The results showed that agno(20-66) was sufficient toiScience 23, 101257, July 24, 2020 5
Figure 3. Agnoprotein Is Sufficient to Mediate Structural and Functional Alterations of Mitochondrial Network
(A) Schematic presentation of agnoprotein-mEGFP fusion constructs transfected into UTA6 cells. Retained aa indicated in
parenthesis and presented as solid line, deleted parts presented as dotted line. The central amphipathic helix (aa 22–39)
is shown as blue bar. Confocal images of transfected UTA6 cells, transiently expressing the indicated agnoprotein-
mEGFP fusion constructs were taken at 24 hpt. Immunofluorescent staining for Tom20 (red), agnoprotein (magenta), GFP
(green), and DNA (blue) (scale bar, 20 mm).
For MTScox8-agno(20-66), Z-stacks were obtained and colocalizing voxels are shown in yellow.
(B) UTA6-2C9 cells stably transfected with tetracycline (tet)-off inducible BKPyV agnoprotein were cultured for 24 h in the
presence (+tet) or absence (tet) of tetracycline to suppress or induce BKPyV agnoprotein expression, respectively.
Confocal images of cells stained for DNA (blue), agnoprotein (green), and Tom20 (red). White rectangle indicating
ll
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enlarged section. Graph representing corresponding mitochondrial morphology, quantification of six fields using Fiji
software of two independent experiments (mean G SD; two-way ANOVA).
(C) Jm was assessed by JC-1 dye and imaging of live cells using the signal ratio of aggregate (red)/monomeric (green)
normalized to UTA6-2C9 cells not expressing agnoprotein (+tet) versus cells expressing agnoprotein (tet) using
Mithras2 (mean G SD, unpaired parametric t test).
(D) Nuclear IRF3 translocation following poly(I:C) transfection was compared in UTA6-2C9 cells cultured for 24 h in the
presence or absence of tetracycline to suppress or induce BKPyV agnoprotein expression, respectively. Increasing
amounts of rhodamine-labeled poly(I:C) was delivered to the cells via lipofection, cells were fixed at 4 hpt, stained for IRF3
(magenta), agnoprotein (green), and DNA (blue) (left images, 1,000 ng/mL poly(I:C), right panel quantification of nuclear
IRF3 of six fields using Fiji software (mean G SD, Mann-Whitney)).
(E) Nuclear IRF3 translocation following poly(dA:dT) transfection was compared in UTA6-2C9 cells as described in D (left
images, 1,000 ng/mL poly(dA:dT), right panel quantification of nuclear IRF3 (mean G SD, Mann-Whitney)).
(F) Quantification of IFN-b mRNA and IFN-b secretion into cell culture supernatants following poly(dA:dT) stimulation of




Articleinduce mitochondrial fragmentation if mitochondrial targeting was provided by the MTScox8 sequence
(Figure 3A, bottom row and extra panels; Video S3). This was not observed for MTScox8-mEGFP targeting
mitochondria but lacking agnoprotein sequences (Figure S3A). To investigate LD binding after addition of
oleate, MTScox8-mEGFP and MTScox8-Agno(20-66)mEGFP were transfected and stained for LD using
4,40-Difluoro-4-bora-(3a,4a)-diaza-s-indacene (bodipy) and Tom70 and analyzed by confocal microscopy
(Figures S3B and S3C). The results showed that MTScox8-agno(20-66)mEGFP were co-localizing to LD
while MTScox8-mEGFP was not. The data indicated that the amphipathic helix present in the aa20–aa66
of truncated MTScox8-agno(20-66)mEGFP fusion protein was available for interaction with LD, presumably
on the surface of mitochondria.
As an independent approach, we examined UTA6-2C9 cells harboring a wild-type full-length agnoprotein
under the control of an inducible tetracycline (tet)-off promoter (Cioni et al., 2013). At 24 h in the absence of
tet (-tet), agnoprotein was expressed in the cytoplasm and colocalized with fragmented mitochondria,
whereas in the presence of tet concentrations suppressing agnoprotein expression (+tet), an intact mito-
chondrial network was seen (Figure 3B). Importantly, inducing agnoprotein was associated with MMP
disruption when examining aggregate (red) and monomeric (green) signals or when using automated
JC-1 dye measurements of the cell cultures (Figure 3C).
Because mitochondria play a key role in innate immunity (Koshiba et al., 2011), UTA6-2C9 cells were
cultured for 24 h in the presence or absence of agnoprotein expression and transfected with either
poly(I:C)RNA or poly(dA:dT)DNA, both of which are potent inducers of the type-1 interferon expression
via cytoplasmic phosphorylation and nuclear translocation of the interferon regulatory factor 3 (IRF3). At
4 hpt, the effect of agnoprotein expression on the nuclear localization of the IRF3 was examined. The results
demonstrated that in the presence of agnoprotein, nuclear IRF3 translocation was significantly reduced af-
ter transfecting poly(I:C) (Figure 3D) or poly(dA:dT) (Figure 3E). To functionally relate the agnoprotein-
dependent differences in nuclear IRF3 translocation, interferon (IFN)-b expression was quantified after
transfection of increasing amounts of poly(dA:dT). The results indicated that agnoprotein expression re-
sulted in a significant reduction of IFN-b transcripts and secreted protein levels (Figure 3F). Together,
the data indicated that the expression of BKPyV agnoprotein was necessary and sufficient to induce mito-
chondrial fragmentation, breakdown of MMP, and impairment of the innate immune sensing of cytosolic
DNA and RNA.
BKPyV Replication Is Inhibited by IFN-b
To determine whether or not BKPyV replication is sensitive to IFN-b, RPTECs were pre-treated, which re-
sulted in an IFN-b dose-dependent reduction of LTag-positive cells and supernatant BKPyV loads at
72 hpi (Figure 4A). SDS/PAGE immunoblot analysis demonstrated an increase of IFN-induced protein
with tetratricopeptide repeats (IFIT) and a reduction of the viral capsid protein Vp1 and agnoprotein (Fig-
ure 4B). A time course of IFN-b addition revealed maximal inhibitory effects before or at 2 hpi, but addition
at 36 hpi still reduced the supernatant BKPyV loads by 50% (Figure 4B). The reduction in supernatant BKPyV
loads could be restored by type-I interferon blockade consisting of a cocktail of blocking antibodies
against IFN-a, IFN-b, and IFN-alpha/beta receptor (Figure 4B). Thus, BKPyV replication in primary human
RPTECs was inhibited by IFN-b but could be prevented by anti-IFN-blockade. To examine the role of ag-
noprotein in BKPyV replication, RPTECs were infected with equivalent infectious doses of Dun-AGN or theiScience 23, 101257, July 24, 2020 7
Figure 4. BKPyV Replication in Primary Human RPTECs Is Sensitive to Type-1 Interferon
(A) RPTECs were treated overnight with the indicated concentrations of IFN-b or solvent. LTag positive cells (left panel;
triplicates, mean G SD, two-way ANOVA) and supernatant BKPyV loads (middle panel; triplicates, mean G SD, two-way
ANOVA) were quantified at the indicated times, and a representative LTag staining of RPTECs at 72 hpi is shown (right
panel).
(B) RPTECs were pre-treated with the indicated concentrations of IFN-b and expression of IFIT1 (ISG56), and BKPyV late
viral proteins Vp1 and agnoprotein were analyzed at the indicated times post-infection by immunoblot analysis (left
panel). RPTECs were treated before or at the indicated times post-infection with 200 U/mL IFN-b, and supernatant BKPyV
loads were measured at 72 hpi (middle panel; triplicates, mean G SD, Kruskal-Wallis test). BKPyV-infected RPTECs were
treated with IFN-b in the presence or absence of anti-IFN consisting of antibodies blocking IFN-a, IFN-b, and interferon a/
b receptor (right panel), and supernatant BKPyV loads were measured at 72 hpi (right panel; duplicates, mean G SD,
unpaired parametric t test).
(C) RPTECs were infected with the indicated BKPyV variants (MOI = 1 by nuclear LTag staining of RPTCs) and the number
of infected cells were quantified by immunofluorescence at 72 hpi (left panel; triplicates, meanG SD, unpaired parametric
t test), and supernatant BKPyV loads were measure at the indicated time post-infection (middle panel; triplicates, meanG
SD, two-way ANOVA). Quantification of IFN-b mRNA in RPTECs infected with the indicated strains was performed at
48 hpi and 72 hpi and normalized to the BKPyV loads (right panel; triplicates, mean G SD, two-way ANOVA).
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(D) RPTECs were infected with BKPyV Dun-agn25D39E, the TBK-1 inhibitor BX795, antibodies blocking IFN-a, IFN-b, and
interferon a/b receptor or solvent were added at 36 hpi, and supernatant BKPyV loads were measured at 72 hpi (left panel;
triplicates of two independent experiments, mean G SD, unpaired parametric t test). RPTECs were infected with BKPyV
Dun-agn25D39E and treated with the indicated concentrations of CoCl2 or solvent at 24 hpi, and at 72 hpi, confocal
microscopy was performed for Tom20 (red), agnoprotein (green) and DNA (blue), and supernatant BKPyV loads




Articlemutant derivatives Dun-agn25D39E and Dun-ATCagn. Although the mutant variants replicated, both had
lower supernatant BKPyV loads at 72 hpi and a reduced number of LTag- and Vp1-positive cells compared
with wild-type virus (Figure 4C). Comparing the IFN-b transcripts at the 48 hpi showed declining levels in
the wild-type virus at 72 hpi but significantly higher levels at both time points after Dun-agn25D39E and
Dun-ATCagn infection (Figure 4C). Similarly, significantly lower IFN-b transcripts normalized to LTAg
transcripts were detected after transfecting RPTECs with the wild-type compared with either of the mutant
genomes at 48 hpt and 72 hpt (Figure S4A).
To investigate whether or not the reduced replication of Dun-agn25D39E could be rescued, the TBK-1-in-
hibitor (Bx795) to prevent IRF3 phosphorylation or the type-1 interferon-blocking cocktail was added at
36 hpi. The results demonstrated that TBK-1 inhibition or type-1 interferon blockade were able to partially
rescue BKPyV Dun-agn25D39E replication (Figure 4C). Under these conditions, there was no effect of TBK-1
inhibition on BKPyV Dun-AGN replication (Figure S4B). Because CoCl2-treatment has been described to
induce functional hypoxia by disrupting the MMP (Jung and Kim, 2004), RPTECs were infected with Dun-
agn25D39E and treated with 150 mM or 300 mM CoCl2 at 24 hpi. Partial mitochondrial fragmentation of
BKPyV Dun-agn25D39E-infected cells was seen together with increased supernatant viral loads at 72 hpi
(Figure 4D). Together, the results indicated that the failure of the agn25D39E mutant protein to disrupt
the MMP and the mitochondrial network was associated with reduced replication, which could be partially
rescued by interfering with innate immune activation, type-1 interferon expression and MMP-dependent
mitochondrial signaling relays.
BecauseMAVS is an important sensor of cytosolic nucleic acids and located onmitochondria, we examined
its distribution in Dun-AGN- and mock-infected RPTECs by confocal microscopy. As shown, MAVS colocal-
ized with both intact and agnoprotein-fragmented mitochondria in RPTECs (Figure 5A). Similarly, MAVS
also colocalized with fragmented mitochondria in UTA6-2C9 cells following tet-off-induced agnoprotein
expression (data not shown). To compare the levels of MAVS in Dun-AGN-infected and mock-treated
RPTECs, cell extracts were analyzed by SDS/PAGE and immunoblotting, showing reduced MAVS levels
following BKPyV Dun-AGN infection (Figure 5B). Sequential immunoblotting for GAPDH as loading control
and for Tom20 revealed a 60%–70% decrease in intensity of the major MAVS band and Tom20 in Dun-AGN-
infected RPTECs compared with non-infected control cells (Figure 5B).
Fragmentation of the mitochondrial network with intact MMP occurs physiologically prior to mitosis and
mitochondria partitioning into daughter cells and involves phosphorylation of the dynamin-related protein
(Drp)1 at S616 by the cell division kinase CDK1/cyclin B (Figure 5C, mock). In BKPyV Dun-AGN-infected
RPTECs, increased Drp1-S616 phosphorylation was detected in Vp1-positive cells but unrelated to mitosis
(Figure 5C, AGN). By SDS/PAGE and immunoblotting, Drp1-S616 phosphorylation was increased in Dun-
AGN-infected cells compared with mock (Figure 5C, right panel), although overall Drp1 levels were similar
(Figure S5A). Comparing isogenic mutant viruses by confocal microscopy revealed that Drp1-S616
phosphorylation was increased in Dun-agn25D39E- and Dun-ATCagn-replicating RPTECs, in which the
mitochondrial network remained intact (Figure S5B). The results indicated that increased Drp1-S616 phos-
phorylation was related to BKPyV infection occurring independent of cell division or expression or function-
ality of agnoprotein. However, agnoprotein-mediated fragmentation of the mitochondrial network was
associated with lowered protein levels of MAVS and Tom20.
Agnoprotein-Disrupted Mitochondria Are Targeted for p62/SQSTM1 Mitophagy
Given the striking differences in mitochondrial network structure by confocal microscopy, we applied by
transmission electron microscopy to examine BKPyV-Dun-AGN- or Dun-agn25D39E-infected RPTECs. At
72 hpi, viral particles in the nucleus served as a marker of the late viral life cycle equivalent to nuclear
Vp1 staining in confocal microscopy. In the cytoplasm of Dun-AGN-infected RPTECs, small disruptedmito-
chondrial vesicles were seen, matching the results obtained by confocal microscopy, as well as severaliScience 23, 101257, July 24, 2020 9
Figure 5. MAVS Colocalizes to Fragmented Mitochondria and Is Decreased in BKPyV-Infected RPTECs
(A) RPTECs were infected with BKPyV Dun-AGN or mock-treated and were either fixed after 72 h for confocal microscopy
staining for DNA (blue), agnoprotein (green), and MAVS (red) (top left panel) or were harvested lysing 2.0 3 104 cells per
10 mL Laemmli Sample Buffer and analyzed by SDS/PAGE and immunoblotting for MAVS and agnoprotein (top panels).
(B) The immunoblot (lower panel) stained for MAVS and agnoprotein (first) was subsequently stained for GAPDH and
Tom20 (second). MAVS and Tom20 levels were normalized to GAPDH levels as indicated (right panel). GAPDH signal was
overlapping with MAVS-specific band (indicated by asterisk) and was subtracted prior normalization.
(C) RPTECs were mock-treated (top panels, left) or infected with BKPyV Dun-AGN bottom panels) and were fixed after
72 h for confocal microscopy for DNA (blue), Vp1 (cyan), MAVS (red), and phosphorylated Drp1-S616 (magenta) (bottom
panels, left). Cell lysates were analyzed by SDS/PAGE and immunoblotting using antibodies to total Drp1,




Articlesmaller densemultilaminar structures. In contrast, longer filamentousmitochondrial structures were seen in
BKPyV Dun-agn25D39E (Figure 6A) in line with tangential cuts of the intact three-dimensional mitochon-
drial network seen by confocal microscopy (Figure S6). Because damaged mitochondria with MMP break-
down are known to be targeted for autophagy, we investigated p62/SQSTM1 as a marker of mitochondrial
autophagosomes (Johansen and Lamark, 2011). At 72 hpi, a significant increase in large confluent p62/
SQSTM1-positive signals was observed in Dun-AGN-infected RPTECs compared with the disperse cyto-
plasmic distribution p62/SQSTM1 in mutant Dun-agn25D39E-infected cells (Figure 6A). Moreover, cyto-
plasmic aggregates of p62/SQSTM1 colocalizing with Tom20 were prominent in Dun-AGN-infected
RPTECs with mitochondrial fragmentation but rare in Dun-agn25D39E-infected cells with intact10 iScience 23, 101257, July 24, 2020
Figure 6. Agnoprotein-Mediated Mitochondrial Fragmentation and p62/SQSTM1-Autophagosomes in Cell
Culture and Kidney Transplant Biopsy Tissue
(A) RPTECs were infected with BKPyV Dun-AGN or BKPyV Dun-agn25D39E. At 72 hpi, cells were fixed and processed for
TEM (top panels; scale bar, 2 mm) or for confocal microscopy (bottom left panels) staining for Tom20 (red), agnoprotein
(green), p62/SQSTM1 (cyan), and DNA (blue). p62/SQSTM1-positive autophagosomes of six fields were quantified using
Fiji at 48 hpi and 72 hpi (bottom right panels; mean G SD, two-way ANOVA).
(B) UTA6-2C9 cells were cultured for 24 h or 48 h in the presence or absence of tetracycline to suppress or induce BKPyV
agnoprotein expression, respectively. At the indicated times, confocal microscopy (left panels) was performed after fixing
and staining for Tom20 (red), agnoprotein (green), p62/SQSTM1 (cyan), and DNA (blue). p62/SQSTM1-positive
autophagosomes were quantified as described in A at 24 h and 48 h (right panels; mean G SD, two-way ANOVA).
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(C) Tissue biopsies from kidney transplant patients with (infected) or without (non-infected) BKPyV-associated
nephropathy were studied by transmission electronmicroscopy (left panels; scale bar, 1 mm) or confocal microscopy (right




Articlemitochondrial networks (Figure S6). Similarly, agnoprotein-dependent p62/SQSTM1 aggregates were
seen in UTA6-2C9 cells at 24 h post-induction, which condensed at 48 h, indicating that agnoprotein-
induced breakdown of the mitochondrial membrane potential and network was followed by p62/
SQSTM1-positive autophagosome formation (Figure 6B).
To investigate whether or not similar changes could be observed in BKPyV-associated nephropathy in kid-
ney transplant patients, allograft biopsy samples were analyzed. Indeed, transmission electron microscopy
revealed small disrupted mitochondria in the cytoplasm of tubular epithelial cells having viral particles in
the nuclei, whereas noninfected tubular epithelial cells showed prominent long mitochondria (Figure 6C).
Immunofluorescent staining of kidney allograft biopsies and confocal microscopy for agnoprotein, Tom20,
and p62/SQSTM1 revealed fragmented mitochondria and p62/SQSTM1 aggregates in agnoprotein-pos-
itive cells in BKPyV-infected parts, which were not seen in non-infected tubular epithelial cells of the
same biopsy core (Figure 6C). Together, the data extended the cell culture results to renal allograft ne-
phropathy, showing that BKPyV replication was associated with mitochondrial fragmentation and p62/
SQSTM1-positive autophagosome formation in kidney transplant patients.
To investigate autophagic flux as a dynamic marker of p62/SQSTM1 mitophagy, the expression levels of
LC3-I and its activated lipid-derivative LC3-II were examined in UTA6-2C9 cells by immunoblotting. In
untreated cells, mostly LC3-I was detected, but in the presence of the lysosomal protease inhibitor pepsta-
tin-A1/E64d, LC3-I increased and LC3-II became apparent as expected for inhibition of the steady-state
autophagic flux (Figure 7A). Following agnoprotein expression, LC3-I and the derivative LC3-II levels
were also increased and increased further in the presence of pepstatin-A1/E64d, indicating that
agnoprotein expression increased the autophagic flux, which could be partly blocked by lysosomal prote-
ase inhibitors (Figure 7A). Treatment with carbonyl cyanide m-chlorophenylhydrazone (CCCP) is known to
chemically disrupt the MMP and to induce PINK-Parkin-dependent mitophagy (Narendra et al., 2008).
Similar to agnoprotein expression, CCCP treatment caused an increase in LC3-I and -II, which further
increased in the presence of pepstatin-A1/E64d (Figure 7A). However, agnoprotein expression followed
by CCCP treatment did not result in a further increase of LC3-I/II levels but rather increased the relative
LC3-II proportion, suggesting that the autophagic flux induced by agnoprotein was further maximized
by CCCP treatment. To investigate the role of parkin in this process, UTA6-2C9 cells were transfected
with a yellow fluorescent protein (YFP)-Parkin expression construct and analyzed by confocal microscopy.
In YFP-transfected UTA6-2C9 cells not expressing agnoprotein (+tet), little colocalization with fragmented
mitochondria was observed. Following the addition of CCCP, extensive cytoplasmic YFP-parkin positive
aggregates overlaid Tom20-positive structures in the cytoplasm (Figure S7, +tet, CCCP, magnification).
In UTA6-2C9 cells expressing agnoprotein (-tet), the YFP-Parkin signals appeared displaced by agnopro-
tein from Tom20-colocalizing structures accumulating in the perinuclear cytoplasm (Figure S7, tet-, magni-
fication). Using isosurface rendering to analyze the agnoprotein-induced mitochondrial fragmentation
supported the notion that Tom20-positive mitochondrial structures were surrounded by agnoprotein-pos-
itive layer, which displaced another layer of YFP-parking (Figure S7, tet-, bottom panels, dashed circle).
Together, the data suggested that despite a shared breakdown of the MMP, CCCP- and agnoprotein-
induced mitophagy appeared to differ in associating directly and indirectly with Parkin, respectively.
To independently investigate the role of p62/SQSTM1 in autophagic flux following BKPyV infection of
RPTECs, LC3 was analyzed in RPTEC with or without siRNA-p62 knockdown. Immunoblotting of the
siRNA-p62 knockdown RPTECs revealed a reduction of p62/SQSTM1 levels to approximately 30% of the
control RPTECs (Figure 7B, left panel). Upon pepstatin-A1/E64d treatment, p62/SQSTM1 levels as well
as the levels of LC3-I and -II increased in the control cells, but not to the same extent in the siRNA-p62
knockdown cells, indicating that the decrease in p62/SQSTM1 levels was associated with lower LC3-II for-
mation and reduced steady-state autophagic flux (Figure 7B, left panel). Following Dun-AGN-infection and
pepstatin-A1/E64 treatment, LC3-I and -II levels increased, but the overall levels were lower in the siRNA-
p62 knockdown cells, and the LC3-II/-I ratio was decreased as well as the Vp1 levels (Figure 7B, left panel).
To investigate the impact of the siRNA-p62 knockdown, whole-cell extracts were prepared and analyzed by
SDS/PAGE immunoblotting for MAVS levels in infected and uninfected RPTECs. The results after12 iScience 23, 101257, July 24, 2020
Figure 7. Agnoprotein Mediates p62/SQSTM1-Dependent Autophagic Flux and Mitophagy
(A) UTA6-2C9 cells were cultured for 48 h in the presence or absence of tetracycline to suppress or induce BKPyV
agnoprotein expression, respectively. At 24 h post-induction, pepstatin-A1/E64d (10 mg/mL) and CCCP (10 mM) were
added as indicated and cell extracts were prepared and analyzed by immunoblotting as described in Transparent
Methods, using RIPA buffer, for LC3-I and II, agnoprotein expression and actin. LC3-II/I ratio were normalized using
untreated cells without agnoprotein (+tet) expression as reference.
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(B) RPTECs transfected with siRNA-p62 (p62 knockdown) or control were infected with BKPyV Dun-AGN (indicated as
AGN). Pepstatin-A1/E64d (10 mg/mL) was added at 48 hpi; when indicated, 2.0 3 104 cells were harvested and lysed per
10 mL Laemmli sample buffer and analyzed by immunoblotting as described in Transparent Methods for p62/SQSTM1,
BKPyV Vp1, and LC3-I and -II expression (on 0.22 mm PVDF membrane, left panel) or MAVS, actin, BKPyV LTag, and
agnoprotein (on 0.45 mm PVDF-FL membrane, right panel).
(C) RPTECs transfected with mCherry-GFP-OMP25TM tandem tag mitophagy reporter were infected with BKPyV Dun-
AGN or BKPyV Dun-agn25D39E. At 72 hpi, cells were fixed and stained for Vp1 and DNA. Colocalization of mCherry and
GFP (yellow), Vp1 (cyan), and DNA (blue). Z-stacks were acquired and analyzed with IMARIS, and the mCherry signal was
transformed into countable spots (according voxel intensity). The GFP and mCherry mean intensity within the spots were




Articlenormalization to actin revealed that MAVS levels were not affected by siRNA-p62 knockdown, but
decreased upon BKPyV-AGN-infection, but which could be partly inhibited in the presence of the lyso-
somal protease inhibitors pepstatin-A1/E64d (Figure 7B, right panel). Together, the data suggested that
BKPyV Dun-AGN infection of RPTECs was associated with an increased p62/SQSTM1-dependent autopha-
gic flux, which involved MAVS degradation and which could be reduced by siRNA-p62 knockdown or
pepstatin-A1/E64d treatment.
To further investigate mitophagy following BKPyV infection, the tandem tag mitophagy reporter mCherry-
mEGFP-OMP25TM carrying the transmembrane domain (TM of OMP25) for targeting to the mitochondrial
outer membrane (Bhujabal et al., 2017) was transfected into RPTECs infected with Dun-AGN or Dun-
agn25D39E. Quantifying the red and green signals in z-stacks of Vp1-expressing cells following confocal
microscopy revealed that the number of mitochondrial signals with mCherry red signals exceeding GFP
green signals were higher in Dun-AGN-infected RPTECs and increased as the number of residual mito-
chondrial fragments progressively decreased in advanced replication phase as compared with Dun-
agn25D39E-infected cells or mock-treated controls (Figure 7C). The data indicated that the mitochondrial
tandem tag reporter was associated with the mitochondrial network in RPTECs infected with Dun-AGN or
Dun-agn25D39E but was progressively disrupted and targeted to the acidic environment of autophago-
somes in the former. Together, the data supported the notion that BKPyV Dun-AGN infection of RPTECs
was associated with increased mitophagy, which was not observed to this extent for infection with the
mutant Dun-agn25D39E.
Mitochondrial Colocalization and Fragmentation of Agnoproteins Is Conserved among
BKPyV, JCPyV, and SV40
To investigate the impact of agnoprotein expression in another BKPyV strain, infection of RPTECs was stud-
ied using a well-characterized, yet slowly replicating BKPyV-WW(1.4) strain carrying an archetype NCCR
(Bethge et al., 2015; Gosert et al., 2008). Similar to Dun-AGN, the BKPyV-WW(1.4) strain showed that agno-
protein expression was associated with mitochondrial fragmentation (Figure 8A). Because agnoprotein ho-
mologues have been identified in the human polyomavirus JCPyV, we examined SVG-A cells infected with
JCPyV-Mad4 strain, for which cytoplasmic agnoprotein expression has been reported previously (Gosert
et al., 2010). Colocalization of JCPyV agnoprotein with Tom20 and mitochondrial fragmentation was
observed (Figure 8B). Moreover, treatment with oleate and staining with LipidTox revealed colocalization
of the JCPyV agnoprotein with LD as has been reported for the BKPyV-encoded agnoprotein (Unterstab
et al., 2010).
SV40 infection was studied in CV-1 cells using Vp2/3-expression in the nucleus as a marker of the late viral
replication phase (Figure 8C). Because SV40 agnoprotein antibodies were not available, we used the partly
cross-reacting antibody raised against the JCPyV agnoprotein together with Tom20 demonstrating frag-
mentation of the mitochondrial network and colocalization with SV40 agnoprotein (Figure 8C). Together,
the data support the view that mitochondrial fragmentation is a conserved feature among different yet
related renotropic polyomaviruses found in human and animal species.
DISCUSSION
In the last decade, significant information has been accumulated about how cytoplasmic sensing of viral
infections is achieved by the innate immune system (Takeuchi and Akira, 2010; Zevini et al., 2017) and
how this crucial first line of defense is subverted to allow for transient or persistent immune escape of acute
and chronic viral infections, respectively (Garcia-Sastre, 2017; Goubau et al., 2013). Despite a high infection14 iScience 23, 101257, July 24, 2020
Figure 8. Agnoprotein of Archetype BKPyV, JC Polyomavirus, and the Simian SV40 Colocalize to Mitochondria
and Disrupt the Mitochondrial Network
(A) RPTECs were infected with BKPyV-WW(1.4) carrying an archetype non-coding control region, and confocal
microscopy was performed at 6 dpi after staining for Tom20 (red), agnoprotein (green), and DNA (blue).
(B) SVG-A cells were infected with JCPyV-Mad4, and confocal microscopy was performed at 72 hpi after staining for
Tom20 (red), anti-JCPyV agnoprotein (green), and DNA (blue) (top panels). Z-stacks of JCPyV-replicating SVG-A cells
were acquired, deconvolved, and processed with IMARIS. 3D isosurface renderings of the mitochondrial marker Tom20
(red), agnoprotein (green), and DNA (blue) are shown. Colocalizing voxels are shown in yellow (middle panels). Confocal
image of SVG-A cells infected with JCPyV-Mad4, 48 hpi, treated with 300 mM oleate at 24 hpi. Cells were stained for lipid
droplets (red), agnoprotein (green), Vp1 (cyan), and DNA (blue). Lipid droplets indicated by white arrow (bottom panels).
(C) CV-1 cells were infected with SV40, and confocal microscopy was performed at 48 hpi after staining for Tom20 (red),




Articlerate (Virgin et al., 2009) and evidence of immune evasion in the general population (Egli et al., 2009; Kaur
et al., 2019), comparatively little is known about relevant mechanisms operating in human polyomaviruses.




Articlereplication by disrupting the mitochondrial network and its membrane potential during the late phase of
the viral replication cycle. Thereby, BKPyV replication is able to evade cytosolic innate immune sensing in
this critical stage of viral progeny accumulation, during which DNA damage (Hein et al., 2009) as well as
abundant viral DNA genomes and RNA transcripts cumulate in the host cell (Funk et al., 2008; Funk
et al., 2006). The precise timing to the critical late viral replication phase (Bernhoff et al., 2008; Low
et al., 2004) allows this window of immune evasion to be equally open following de novo cell infection or
intracellular reactivation, permitting viral cell-to-cell spread in the renal tubules below the radar of the im-
mune system.
Transfection experiments using the entire agnoprotein or different subdomains fused to the reporter
mEGFP as well as the tet-off inducible agnoprotein expression indicate that agnoprotein is necessary
and sufficient, using its amino-terminal and central helix for mitochondrial targeting and mitochondrial
disruption, respectively. As expected from the key role of mitochondria in relaying innate immune sensing,
the agnoprotein-mediated disruption of the MMP was associated with significantly reduced IRF3 translo-
cation into the cell nucleus as well as lowered IFN-b transcript and protein expression following poly(I:C)
RNA or poly(dA:dT)DNA stimulation. Importantly, BKPyV viral variants either lacking agnoprotein expres-
sion due to a start codon mutation (Dun-ATCagn) or carrying mutations abrogating the amphipathic char-
acter of the central helix (Dun-agn25D39E) showed intact mitochondrial networks and little mitophagy but
significantly impaired replication compared with the wild-type strain Dun-AGN. The lower replication rate
of the mutant Dun-agn25D39E could be partially reversed on three levels of the mitochondrial innate im-
mune relay, namely by CoCl2 treatment affecting the respiratory chain and disrupting the MMP (Jung and
Kim, 2004), by BX795 inhibiting the downstream signaling kinase TBK-1, or by type-1 interferon blockade.
Our study also reveals for the first time a critical role of mitophagy in polyomavirus biology. Mitophagy is
known to assist in the disposal of irreversibly damagedmitochondria including the irreversible disruption of
the MMP as mediated by the wild-type agnoprotein. MAVS remains colocalized to the agnoprotein-medi-
ated mitochondrial fragments targeted for mitophagy leading to significantly lower levels after BKPyV
DUN-AGN infection, which could be partially reversed by pepstatin-A1/E64d protease inhibition or by
siRNA-knockdown of p62/SQSTM1. Thus, the MMP breakdown and network fragmentation appears to
be the immediate key event preventing the activation of the innate immune sensing, to which mitophagy
including MAVS or potentially STING degradation follow as common secondary events. The pepstatin-A1/
E64d protease inhibition and siRNA knockdown experiments also indicate that agnoprotein increases the
p62/SQSTM1-dependent steady-state autophagic flux via LC3-II lipidation in a fashion similar to the one
observed following the CCCP-induced mitochondrial membrane potential breakdown (Johansen and La-
mark, 2011). Although CCCP-induced mitophagy has been reported to directly involve the PINK-Parkin
pathway (Bhujabal et al., 2017), our results indicate that mitophagy by agnoprotein involves shifting Parkin
by an agnoprotein layer away from the fragmented mitochondria. Confocal microscopy and comparison of
LCI/II levels indicate that mitophagy by agnoprotein can be further increased by CCCP. Together, this
suggests that the agnoprotein-mediated mitophagy appears to differ from the direct CCCP-induced Par-
kin-involving process. Further evidence for increased autophagic flux was obtained using the tandem tag
mitophagy reporter mCherry-mEGFP-OMP25TM revealing acidification in mitophagosomes of BKPyV-
AGN-infected RPTECs, which was not observed to the same extent in agn25D39E-mutant-infected
RPTECs. Notably, pepstatin-A1/E64d protease inhibition and p62-siRNA knockdown were associated
with the reduced Vp1-protein levels in BKPyV Dun-AGN-infected primary human RPTECs. This observation
suggests that the autophagic flux may be relevant for the effective biosynthesis in the exhaustive late viral
replication phase following the functional and structural loss of the mitochondrial power plants (Forbes,
2016). However, the precise adaptor proteins and pathways need further study (Farre and Subramani,
2016).
Innate immune sensors have been characterized in primary human RPTECs and in kidney biopsies by tran-
scriptional profiling identifying antiviral, proinflammatory, and proapoptotic responses (Heutinck et al.,
2012; Ribeiro et al., 2012). Other studies reported that BKPyV infection of RPTECs can occur without
inducing innate immune sensors by as yet unknown mechanisms (Abend et al., 2010; An et al., 2019; de
Kort et al., 2017). However, these studies failed to reveal inhibition of BKPyV replication by type-1 inter-
ferons, which is in contrast to our results for BKPyV shown here and those recently reported for JCPyV
(Assetta et al., 2016). We show that wild-type BKPyV is susceptible to IFN-b, an effect that can be blocked




ArticleATCagnmutants compared with the wild-type Dun-AGN virus. Indeed, type-I interferon blockade and the
TBK-1 inhibition partially reversed the reduced replication of themutant Dun-agn25D39E virus in line with a
higher basal IFN-b transcript expression in the agnomutant compared with wild-type virus, whereas TBK-1
inhibition has no effect on the wild-type BKPyV-Dun replication.
Importantly, confocal and transmission electron microscopy studies of biopsies obtained from kidney
transplant patients provide independent evidence of mitochondrial fragmentation and p62/SQSTM1 mi-
tophagy in vivo. These data suggest that the combined effects of immune escape, mitophagy, and viral
spread are operating not only in a relevant primary human cell culture model of RPTECs but also in one
of the currently most challenging pathologies affecting kidney transplantation (Ramos et al., 2009). Intrigu-
ingly, the BKPyV-agnoprotein-induced immune subversion and p62/SQSTM1 mitophagy may explain the
earlier reported paradox of abundant detection of agnoprotein in vivo and the low agnoprotein-specific
antibody and T cell response (Leuenberger et al., 2007) and provide a new twist to BKPyV-promoting hyp-
oxic mechanisms following renal ischemia/reperfusion injury (Atencio et al., 1993; Fishman, 2002; Hirsch
et al., 2006).
Our results also shed new light on previous reports on BKPyV agnoprotein and the closely related JCPyV
and SV40 homologues (Gerits and Moens, 2012; Saribas et al., 2019): These include facilitating polyomavi-
rus replication (Ng et al., 1985), increasing viral late-phase production (Carswell et al., 1986) and plaques
size (Hou-Jong et al., 1987), acting as viroporin (Suzuki et al., 2010) or egress factor (Panou et al., 2018)
from the nucleus, by disrupting the tight surrounding mitochondrial network. We demonstrate that mito-
chondrial fragmentation occurs not only for BKPyV strains carrying an archetype NCCR but also for the
human JCPyV or the monkey SV40, suggesting that this dramatic agnoprotein-mediated function is evolu-
tionary conserved and active across different species, cell types, and hosts. In line with this notion, we were
unable to identify relevant point mutations in the critical amphipathic wheel of agnoprotein among more
than 300 whole genome sequences available in the GenBank (unpublished data) (Leuzinger et al., 2019).
Thus, we conclude that the small agnoprotein of less than 66 aa facilitates BKPyV replication by an effective
mechanism also seen in other renotropic human and animal polyomaviruses, which is unmatched in other
DNA viruses through its dramatic simplicity (Koshiba et al., 2011).
Indeed, rather complex viral mechanisms have been described targeting the cytosolic sensing platforms at
steps up- and downstream of mitochondria and associated ER membranes (Khan et al., 2015). Thus, the
matrix protein (M-protein) of parainfluenza-3 has been reported to translocate to mitochondria, where it
induces mitophagy via LC3-II in a PINK/Parkin-independent manner (Ding et al., 2017). However, the M-
protein is a structural protein and according to the current model acts early following entry into host cells
and requires piggy-back import via the mitochondrial elongation factor TUFM (Ding et al., 2017), whereas
our study indicates that the non-structural BKPyV agnoprotein targets mitochondria directly during the late
replication phase. Unlike BKPyV, HCV and other (+)-ssRNA viruses replicating in the cytoplasm appear to
induce mitochondrial fragmentation and mitophagy in a PINK-Parkin-dependent fashion (Gou et al., 2017).
Although structurally unrelated to agnoprotein, the 247aa-long cytomegalovirus (CMV) US9 glycoprotein
appears to suppress both MAVS and STING pathways, TBK-1 activation, and IFN-b expression by disrupt-
ing the mitochondrial membrane potential in the late CMV replication phase (Choi et al., 2018; Mandic
et al., 2009). Given the association of agnoprotein with LD, we were intrigued by the similarity to the anti-
viral host cell protein viperin, which is expressed following RNA and DNA virus infections (Gizzi et al., 2018;
Hee and Cresswell, 2017). The antiviral effects of viperin have been attributed to a perplexing variety of
functions including interference with lipid metabolism and formation of detergent-resistant lipid rafts at
the sites of influenza budding (Wang et al., 2007). Similar to agnoprotein, viperin contains an amphipathic
helix required for adsorbing to the cytosolic face of LD and ER membranes (Hinson and Cresswell, 2009a,
b). However, viperin may facilitate viral replication (Hee and Cresswell, 2017), when re-directed to mito-
chondria by the CMV-encoded Bax-specific inhibitor viral mitochondria-localized inhibitor of apoptosis
(vMIA) carrying a mitochondrial targeting domain (Cam et al., 2010; Seo et al., 2011). Thus, the hijacked vi-
perin-CMV-vMIA complex shares properties accommodated in only 66aa of BKPyV agnoprotein.Limitations of the Study
We cannot exclude a more direct role of agnoprotein on STING signaling through MMP breakdown or
through its ER colocalization. Current concepts suggest that BKPyV as a DNA virus would be expected




Articleinteraction between DNA- and RNA-sensing pathway coupling MAVS and STING activation on mitochon-
dria and ER to TBK-1 activation downstream including through RNA-polymerase III transcription of cyto-
plasmic DNA-fragments (Chiu et al., 2009; Zevini et al., 2017). Our results demonstrate that agnoprotein
expression alone is sufficient to inhibit innate immune responses to both poly(I:C)-RNA and poly(dA:dT)-
DNA.
Even though our study indicates that agnoprotein is both necessary and sufficient for MMP breakdown and
mitochondrial fragmentation, it is presently unclear, whether or not this is achieved by the direct interaction
with cellular proteins other than the mitochondrial import machinery. Experimental MMP breakdown by
CCCP has been shown to also suppress STING signaling, further merging the cytosolic RNA- and DNA-trig-
gered responses (Kwon et al., 2017). Finally, details of the mitophagy process, the role of the involved pro-
teins, and their direct or indirect interaction require further study.
Given the abundance of BKPyV agnoprotein in the cytoplasm and the clearly distinct colocalization pat-
terns to ER in addition to mitochondria, further studies need to be carefully conducted in order to avoid
misleading artifacts. For the Bcl-2 family of proteins, a hierarchy of interactome complexes has emerged
over the last decade (Bleicken et al., 2017; Edlich et al., 2011). Moreover, for the related JCPyV agnoprotein,
a strong tendency to form multimeric aggregates in vitro has been reported (Sami Saribas et al., 2013),
which undoubtedly reduces the specificity of otherwise straight-forward pull-down approaches and com-
plicates potential functional attributions. This notion has been recently confirmed by a detailed study of
potential proteomic interaction partners for the homologous JCPyV agnoprotein (Saribas et al., 2019).
Presently, we favor a minimal model (Figure 9) in which mitochondrial targeting of N-terminal domain of
agnoprotein allows for embedding the central amphipathic helix into the outer leaflet of the outer mito-
chondrial membrane similar to other amphipathic proteins, where it remains available for LD-binding. In-
direct support comes from the recruitment of LD to the MTScox8-agno(20-66)mEGFP not observed for
MTScox8-mEGFP following transfection and oleate treatment. However, further studies are needed to
investigate whether or not this simple plug-and-play suffices to progressively leaking protons and causing
the loss of membrane potential, preventing TBK-1 activation, and targeting for p62/SQSTM1 mitophagy
(Jarsch et al., 2016; McMahon and Gallop, 2005; Shen et al., 2012).
In summary, our study provides important novel perspectives into how BKPyV replication is effectively facil-
itated in the critical late phase of the viral life cycle by the small accessory agnoprotein in at least three com-
plementary ways: (1) inactivating immune sensing and the inhibitory effects of interferon-b expression by
breakdown of the mitochondrial membrane potential; (2) enhancing the supply of biosynthetic building
blocks via increased autophagic flux, and (3) facilitating viral release of nuclear virions by fragmenting
the nucleus-surrounding mitochondrial network. Finally, our observations suggest that BKPyV agnoprotein
is not only important for immune escape and urinary shedding in healthy immunocompetent hosts but may
also facilitate the rapid cell-to-cell spread inside the renal tubules, and hence the progression to BKPyV
nephropathy in kidney transplant patients. These insights may help to design novel antiviral and immuni-
zation strategies and permit identifying novel markers readily distinguishing BKPyV nephropathy from allo-
graft rejection (Hirsch and Randhawa, 2019).Resource Availability
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Figure 9. Working Model of BKPyV Agnoprotein Mediating Innate Immune Evasion by Mitochondrial Membrane





All methods can be found in the accompanying Transparent Methods supplemental file.
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Figure S1. Comparing the prediction of mitochondrial presequence BKPyV 
agnoprotein, point mutant derivatives and cytochrome c oxidase cox8, related to 
Figure 1. 
A mitochondrial presequence was predicted within the blue bar of the first 25 amino acids with 
a precision of 0.79 and a recall of 0.80 using the MitoFate prediction tool 
(http://mitf.cbrc.jp/MitoFates/cgi-bin/top.cgi, accessed 26.02.2020) for the amino acids 
encoded in the AGN, agn25D39E, agn25L39L sequences and for the mitochondrial targeting 




Figure S2. BKPyV early and late viral protein expression in primary human RPTECs, 
related to Figure 1. Cells were infected with the indicated viral strains, fixed at 48 hpi, 
stained for confocal microscopy and z-stack acquisition (see Transparent Methods).  
(A) BKPyV Dun-AGN: DNA (blue), early viral LTag (red), late viral Vp1 (cyan), and 
agnoprotein (green). 
(B) BKPyV Dun-agn25D39E: DNA (blue), early viral LTag (red), late viral Vp1 (cyan), and 
agnoprotein (green). 
(C) BKPyV Dun-agn25D39E: DNA (blue), Tom20 (magenta), agnoprotein (green), PDI (red). 
Colocalizing voxels are shown in yellow. 
 
Figure S3. MTScox8-mEGFP and MTScox8-Agno(20-66)mEGFP colocalize to 
mitochondria, but only MTScox8- Agno(20-66)mEGFP disrupts mitochondrial network 
and binds to lipid droplets (LD), related to Figure 3.  
(A) Confocal images of transfected UTA-6 cells, transiently expressing MTScox8-mEGFP 
fusion protein at 24 hpt. DNA (blue), Tom20 (red), and mEGFP (green). 
(B) Confocal images of transfected Vero cells, transiently expressing MTScox8-mEGFP or 
MTScox8-Agno(20-66)mEGFP fusion proteins at 24 hpt. Left panels in the absence (- 
oleate): DNA (blue), Tom70 (red), and mEGFP (green). Right panels in the presence of 300 
µM oleate (+ oleate). DNA (blue), Tom70 (magenta), mEGFP (green), and LD (red). 
(C) Confocal images of transfected Vero cells, transiently expressing MTScox8- Agno(20-
66)mEGFP fusion proteins at 24 hpt in the presence of 300 µM oleate (+ oleate). DNA 
(blue), Tom70 (magenta), mEGFP (green), and LD (red). 
 
 
Figure S4. Characterization of Interferon- in wildtype and agnomutant BKPyV 
replication, related to Figure 4. 
(A) Interferon- expression is increased in mutant BKPyV Dun-agn25D39E and Dun-
ATCagn compared to the wildtype BKPyV Dun-AGN. 
RPTECS were transfected with genomic viral DNA of the indicated viral variants, and total 
RNA was analyzed at the indicated hours posttransfection (hpt) for LTAg and Interferon- 
expression levels, and the results normalized for 36 hpt (triplicates, mean ± SD, 2-Way 
ANOVA).   
(B) BKPyV-Dun-AGN replication is not affected by TBK-1 inhibition under conditions 
mediating partial rescue of BKPyV Dun-agn25E39D replication.  
RPTECS were infected with BKPyV Dun-AGN, the TBK-1 inhibitor BX795 or solvent were 
added at 36 hpi, and supernatant BKPyV loads were measured at 72 hpi, input virus load is 
indicated by the 24 hpi time-point (triplicates of two independent experiments, mean ± SD, 




Figure S5. Phosphorylation of Drp1 at serine 616 (Drp1-S616) is increased in BKPyV 
variants expressing the amphipathic helix mutant (BKPyV Dun-agn25D39E) or no 
agnoprotein (BKPyV Dun-ATCagn), related to Figure 5. 
(A) RPTECs were infected with BKPyV-Dun-AGN or mock-treated and at 72 hpi, cell lysates 
were prepared using RIPA buffer, and analysed by SDS/PAGE and immunoblotting using 
antibodies to Drp1-total protein (red triangle), BKPyV LTag (green triangle), Vp1, and 
agnoprotein. 
(B) RPTECs were infected with Dun-agn25D39E, Dun-ATCagn, or mock-treated and confocal 




Figure S6. BKPyV Dun-AGN-replicating RPTECs show mitochondrial fragmentation 
and increased Tom20-p62/SQSTM1 colocalization compared to BKPyV Dun-
agn25D39E-replicating RPTECs, related to Figure 6. 
 
RPTECs were infected with BKPyV Dun-AGN or Dun-agn25D39E and at 72 hpi confocal 
microscopy was performed for Tom20 (red), agnoprotein (green), p62/SQSTM1 (cyan), and 
DNA (blue). Colocalizing voxels shown in yellow. 
 
Figure S7. UTA6-2C9 cells transfected with YFP-Parkin show parkin-positive 
mitophagy following CCCP treatment, but displacement by interjacent agnoprotein 
layer following agnoprotein expression, related to Figure 7. 
UTA6-2C9 cells harboring the tetracycline (tet)-off inducible BKPyV agnoprotein were 
transfected with yellow-fluorescence protein-Parkin construct, and confocal microscopy was 
performed at 48 hpt. BKPyV agnoprotein suppression (tet+) and expression (tet-) is 
indicated, respectively. CCCP treatment (10 µM) for 3 h served as positive control for parkin-
positive mitophagy. Confocal images of cells stained for DNA (blue), Tom20 (red), YFP-
parkin (yellow), and agnoprotein (green). Magnification and 3D-isosurface rendering 
showing agnoprotein layer (green) displacing YFP-parkin layer (yellow). Dashed circle marks 
area on mitochondria (red) where YFP-parkin (yellow) is displaced by agnoprotein (green). 
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o QUANTIFICATION AND STATISTICAL ANALYSIS 
• Statistics 
 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Rabbit polyclonal anti-BKPyV agno (clone 81038) (Rinaldo et al., 1998) N/A 
Rabbit polyclonal anti-aa52-66 BKPyV agno (clone 753) This paper (unpublished) N/A 
Rabbit polyclonal anti-aa40-53 BKPyV agno (clone 1163) This paper (unpublished) N/A 
Rabbit polyclonal anti-aa40-59 JCPyV agno (clone 1172) This paper (unpublished) N/A 
Rabbit polyclonal anti-BKPyV LTag (clone 81048) (Rinaldo et al., 1998) N/A 
Mouse monoclonal IgG2a anti-SV40 LTag Calbiochem Cat#PAb416 
Mouse monoclonal IgG1 anti-BKPyV Vp1 Abnova Cat#MAB3204-M19 
Rabbit polyclonal anti-SV40 Vp2/Vp3 Abcam Cat#ab53983 
Mouse monoclonal IgG2a anti-Tom20 Santa Cruz Cat#sc-17764 
Mouse monoclonal IgG2a anti-MAVS Santa Cruz Cat#sc-166583 
Mouse monoclonal IgG1 anti-IRF3 Novus Biological Cat#NBP1-04308 
Mouse monoclonal IgG1 anti-Interferon  pbl assay science Cat#21116-1 
Mouse monoclonal IgG1 anti-Interferon  pbl assay science Cat#21400-1 
Mouse monoclonal IgG1 anti-Interferon  receptor chain 2 pbl assay science Cat#21385-1 
Mouse monoclonal IgG1 anti-p62/SQSTM1 Santa Cruz Cat#sc-28359 
Guinea pig polyclonal anti-p62/SQSTM1 Progen Cat#GP62-C 
Mouse monoclonal IgG1 anti-PDI Enzo Life Cat#SPA-891 
Chicken polyclonal anti-Calreticulin Abcam Cat#ab14234 
Rabbit polyclonal phosphor-Drp1(Ser616) Cell Signalling Cat#3455 
Mouse monoclonal IgG1 anti-Drp1 Novus Biologicals Cat#23489 
Mouse monoclonal IgG2b anti-STING R&D Systems Cat#MAB7169 
Polyclonal rabbit anti-LC3A/B Cell Signalling Cat#4108S 
Mouse monoclonal IgG1 anti-beta Actin Abcam Cat#ab6276 
Mouse monoclonal IgG1 anti-Tubulin Invitrogen Cat#A-11126 
Mouse monoclonal IgG anti-GAPDH Santa Cruz Cat#sc-47724 
Goat anti-mouse IgG2a Alexa Fluor 568 Invitrogen Cat#A-21134 
Donkey anti-rabbit Alexa Fluor 647 Abcam Cat#ab150075 
Goat anti-mouse IgG1 Alexa Fluor 488 Invitrogen Cat#A-21121 
Goat anti-mouse IgG1 Alexa Fluor 647 Invitrogen Cat#A-21240 
Goat anti-mouse IgG2b Alexa Fluor 647 Invitrogen Cat#A-21242 
Goat anti-chicken Alexa Fluor 488 Invitrogen Cat#A-11039 
Goat anti-rabbit Alexa Fluor 488 Abcam Cat#ab150077 
Donkey anti-guinea pig IRDye 680RD LI-COR Cat#926-68077 
Donkey anti-mouse Alexa Fluor 680 Invitrogen Cat#A-10038 
Goat anti-rabbit IRDye 800CW LI-COR Cat#926-32211 
Donkey anti-goat IRDye 800CW LI-COR Cat#926-32214 
Bacterial and Virus Strains  
BKPyV Dunlop-AGN, GENBANK: V01108.1 (Henriksen et al., 2015) N/A 
SV40 (776 strain), GENBANK: AF316139.1 (Henriksen et al., 2016) N/A 
JCPyV Mad-4 ATCC Cat#ATCC VR-1583 
BKPyV-WW(1.4), GENBANK: AB211371.1 (Gosert et al., 2008) N/A 
Chemicals, Peptides, and Recombinant Proteins 
Oleate Sigma-Aldrich Cat#O1383 
JC-1 dye Invitrogen Cat#T3168 
Hoechst 33342 Invitrogen Cat#H21492 
LipidTox Red Molecular Probes H34476 
Poly(I:C) (HMW) Rhodamine InvivoGen Cat#tlrl-picr 
Poly(dA:dT) Rhodamine InvivoGen Cat#tlrl-patrh 
ViaFect Promega Cat#E4982 
Lipofectamine 3000 Thermo Fisher Cat#L3000001 
IFN-beta 1a pbl assay science Cat#11410-2 
BX795 Selleck Chemicals Cat#S1274 
CoCl2 Sigma-Aldrich Cat#C8661 
Tetracycline Sigma-Aldrich Cat#T7660 
CCCP Sigma-Aldrich Cat#C2759 
Pepstatin A1 Enzo Life Science Cat#ALX-260-085 
E64d Enzo Life Science Cat#BML-PI107 
Critical Commercial Assays 
VeriKine-HsTM Human IFN Beta Serum ELISA KIT pbl assay science Cat#41415 
High Capacity cDNA reverse transcript kit Applied Biosystems Cat#4368814 
QIAshredder kit Qiagen Cat#79654 
RNeasy Mini kit Qiagen Cat#74106 
Human Interferon b1 assay Thermo Fisher Scientific Cat#4331182 
Human-HPRT1 endogenous control Applied Biosystems Cat#4333768F 
Experimental Models: Cell Lines 
RPTEC (Lot: 5111) ScienCell 4100 
CV-1 ATCC ATCC CCL-70 
SVG-A (Henriksen et al., 2014) N/A 
Vero E6 ATCC ATCC No. CRL-1586 
UTA6-2C9 (Cioni et al., 2013) N/A 
Oligonucleotides 
SMARTpool siGENOME SQSTM1 siRNA Dharmacon Cat#M-010230-00-0005 
siGENOME Non-Targeting siRNA #2 Dharmacon Cat#D-001210-02-05 
BKPyV qPCR primer F: AGCAGGCAAGGGTTCTATTACTAAAT (Hirsch et al., 2016) N/A 
BKPyV qPCR primer R: GAAGCAACAGCAGATTCTCAACA (Hirsch et al., 2016) N/A 
BKPyV qPCR probe: FAM-
AAGACCCTAAAGACTTTCCCTCTGATCTACACCAGTTT-TAMRA 
(Hirsch et al., 2016) N/A 
Recombinant DNA 
Agno(1-66)-mEGFP (Unterstab et al., 2010) N/A 
Agno(1-53)-mEGFP (Unterstab et al., 2010) N/A 
Agno(1-20)-mEGFP (Unterstab et al., 2010) N/A 
Agno(20-66)-mEGFP (Unterstab et al., 2010) N/A 
Agno(42-66)-mEGFP (Unterstab et al., 2010) N/A 
MTScox8-Agno(20-66)-mEGFP This paper (unpublished) N/A 
MTScox8-mEGFP This paper (unpublished) N/A 
mCherry-mEGFP-OMP25TM reporter plasmid (Bhujabal et al., 2017) N/A 
pUC57-BKPyV-Dun (Unterstab et al., 2010) N/A 
pUC57-BKPyV-Dun-agn25D39E (Unterstab et al., 2010) N/A 
pUC57-BKPyV-Dun-ATCagn This work N/A 
YFP-Parkin (Narendra et al., 2010) Addgene Plasmid #23955 
Software and Algorithms 
GraphPad Prism software (version 8.1.0) GraphPad https://www.graphpad.com 
Fiji Fiji https://fiji.sc 
Huygens professional software (version 19.10) Scientific Volume Imaging https://svi.nl/Huygens-
Professional 





• Cell lines and viruses 
Primary human renal proximal tubular epithelial cells (RPTEC Lot:5111; 4100, ScienCell) 
were maintained in epithelial cell medium (EpiCM; 4101, ScienCell) and passaged with 
Trypsin (T3924, Sigma-Aldrich) and Defined Trypsin Inhibitor (DTI; R007100, Invitrogen). 
UTA6-2C9 cells stably transfected with the AGN gene under a tetracyclin-dependent 
suppressor (tet-off) have been described previously (Cioni et al., 2013). The African green 
monkey kidney cell line CV-1 (ATCC CCL-70) was cultured in Dulbecco’s modified Eagle’s 
medium (D5671, Sigma-Aldrich) supplemented with 5% FBS (S0115, Biochrom) and 2 mM 
Stable Glutamine (5-10K50-H, Amimed). The SVG-A cells (generous gift from C. Hanssen-
Rinaldo) were kept in Minimum Essential Medium (M2279, Sigma-Aldrich) including 10% 
FBS. One day after seeding, RPTEC were infected with BKPyV Dunlop at a MOI of 1.0 
determined by nuclear LTag staining on RPTECs. The infection was carried out for 2 h 
before surplus infectious units were removed and EpiCM containing 0.5% FCS was added. 
One day after seeding, CV-1 cells were infected with SV40 (776 strain) at a MOI of 0.5-1.0 
pfu/cell using a supernatant from SV40-infected BS-C-1 cells. The infection was carried out 
for 2 h before surplus infectious units were removed and complete medium added. One day 
after seeding, SVG-A cells were infected with JCPyV Mad-4 using a supernatant from 
JCPyV Mad-4 transfected COS-7 cells. The infection was carried out for 2 h before surplus 




The following reagents were used (Table 1). Nuclei were stained with Hoechst 33342 
(Invitrogen, H21492). To measure mitochondrial membrane potential, cells were stained with 
5 µM JC-1 dye (T3168, Molecular Probes) for 30 minutes at 37°C, washed twice with D-PBS 
for 5 min, followed by addition of live cell imaging solution (A14291DJ, Thermo Fisher). The 
cells were illuminated at 488 nm and the emission was measured between 515/545 nm and 
575/625 nm with Mithras2 (Berthold Technologies GmbH & Co. KG, Bad Wildbad Germany) 
or the Safire II plate reader (Tecan, Maennedorf, Switzerland). Mock infected- or no 
agnoprotein-expressing cells were set to 100%. To induce LDs, culture medium was 
supplemented with 300 μM oleate (O1383, Sigma-Aldrich) bound to essentially fatty acid 
free bovine albumin (A6003; Sigma-Aldrich) as described (Unterstab et al., 2010). Poly(I:C) 
(HMW) Rhodamine (tlrl-picr, InvivoGen) or Poly(dA:dT) Rhodamine (tlrl-patrh, InvivoGen) 
was transfected with ViaFect™ Transfection Reagent (E4982, Promega) at a reagent: DNA 
ratio of 3:1 according to manufacturer’s instructions. As TBK-1 inhibitor BX-795, (S1274, 
Selleck Chemicals) was used. BX-795 stock was diluted in DMSO and a stock concentration 
of 10 mM was generated. CCCP powder (C2759, Sigma-Aldrich) was diluted in DMSO to 
generate a stock concentration of 100 mM. The protease inhibitors pepstatin A1 (ALX-260-
085, Enzo Life Science) and E64d (BML-PI107, Enzo Life Science) were diluted to generate 
a 10 mg/mL stock concentration in DMSO and Ethanol, respectively.  
 
• Antibodies 
Goat anti-mouse IgG2a Alexa Fluor 568 (A21134, Invitrogen), donkey anti-rabbit Alexa Fluor 
647 (Abcam, ab150075), goat anti-mouse IgG1 Alexa Fluor 488 (A-21121, Molecular 
Probe), goat anti-mouse IgG1 Alexa Fluor 647 (A-21240, Invitrogen), goat anti-mouse IgG2b 
Alexa Fluor 647 (A21242, Molecular Probes), goat anti-chicken Alexa Fluor 488 (A11039, 
Molecular Probes), goat anti-rabbit Alexa Fluor 488 (ab150077, Abcam), donkey anti-guinea 
pig IRDye 680RD (926-68077, LI-COR) donkey anti-mouse Alexa Fluor 680 (A10038, 
Invitrogen), goat anti-rabbit IRDye 800CW (926-32211, LI-COR), donkey anti-goat IRDye 
800CW (926-32214, LI-COR), polyclonal rabbit anti-aa40-59 JCPyV agno-sera (generated 
on request by Eurogentec, Belgium), polyconal anti-BKPyV agnosera (generous gift from C. 
Hanssen-Rinaldo, clone 81038), polyclonal rabbit anti-aa52-66 BKPyV agno-sera 
(generated on request by Eurogentec, Belgium, clone 753), polyclonal rabbit anti-aa40-53 
BKPyV agno-sera (generated on request by Eurogentec, clone 1163), polyclonal rabbit anti-
BKPyV LTag sera (generous gift from C. Hanssen-Rinaldo, clone81048), mouse monoclonal 
IgG2a anti-SV40-LTag cross-reacting with BKPyV LTag (PAb416, Calbiochem), mouse 
monoclonal IgG1 anti-BKPyV Vp1 (MAB3204-M19, Abnova), polyclonal rabbit anti-SV40 
Vp2/Vp3 (ab53983, Abcam), mouse monoclonal IgG2a anti-Tom20 (sc-17764, Santa Cruz), 
mouse monoclonal IgG2a anti-MAVS (sc-166583, Santa Cruz), mouse monoclonal IgG1 
anti-IRF3 (NBP1-04308, Novus Biologicals), mouse monoclonal IgG1 anti-Interferon  
(21116-1, pbl assay science), mouse monoclonal IgG1 anti-Interferon  (21400-1, pbl assay 
science), mouse monoclonal IgG2a anti-Interferon    receptor chain 2 (21385-1, pbl assay 
science), mouse monoclonal IgG1 anti-p62/SQSTM1 (sc-28359, Santa Cruz), polyclonal 
guinea pig anti-p62/SQSTM1 (GP62-C, Progen), mouse monoclonal IgG1 anti-PDI (SPA-
891, Enzo Life Science), polyclonal chicken anti-Calreticulin (ab14234, Abcam), polyclonal 
rabbit anti-Phospho-Drp1-(Ser616) (3455, Cell Signalling), mouse monoclonal IgG1 anti-
Drp1 (NBP2-23489, Novus Biologicals), mouse monoclonal IgG2b anti-STING (MAB7169, 
R&D Systems), polyclonal rabbit anti-LC3A/B (4108S, Cell Signalling), mouse monoclonal 
IgG1 anti-beta Actin (ab6276, Abcam), mouse monoclonal IgG1 and anti-Tubulin (A-11126, 
Molecular Probes), mouse monoclonal IgG1 anti-GAPDH (sc-47724, Santa Cruz). 
 
• Quantitative nucleic acid testing (QNAT) 
BKPyV loads were quantified form cell culture supernatant as described previously (Hirsch 
et al., 2016). To quantify interferon- transcripts, cellular RNA was extracted using the 
QIAshredder kit and the RNeasy Mini kit (79654 and 74106, Qiagen). The cDNA was 
generated using High Capacity cDNA reverse transcript kit (4368814, Applied Biosystems) 
and RT-QNAT was performed on a Veriti 96 Well Thermal Cycler (Applied Biosystems, 
Lincoln, USA) using a human interferon b1 assay (4331182, Thermo Fisher Scientific) and 
human HPRT1 endogenous control (4333768F, Applied Biosystems). LTag transcripts were 
measured as described (Bernhoff et al., 2008). 
 
• Plasmids 
The different agnoprotein constructs and the plasmids containing the full genomes of BKPyV 
Dun-AGN, Dun-agn25D39E have been described in (Unterstab et al., 2010). The plasmid 
harboring the BKPyV Dun-ATCagn is a derivate of the DUN-AGN constructed by site-
directed mutagenesis. Mitochondrial membrane localization signal (MTS) of cytochrome c 
oxidase cox8 was N-terminally fused to agno(20-66)-EGFP and named MTScox8-Agno(20-
66). The mCherry-mEGFP-OMP25TM tandem tag mitophagy reporter was a generous gift of 
Professor Terje Johansen, UiT The Arctic University of Norway, Tromsø, Norway. The YFP-
Parkin plasmid was a gift from Richard Youle (Addgene plasmid # 23955; 
http://n2t.net/addgene:23955 ; RRID:Addgene_23955)(Narendra et al., 2008). 
 
• Transfection 
Transfection of BKPyV genomic DNA or plasmids containing the agnoprotein into RPTECs 
or UTA6 cells was performed at 90-95% confluency using ViaFect™ Transfection Reagent 
(E4982, Promega) at a reagent: DNA ratio of 3:1 according to manufacturer’s instructions. At 
24 h post-transfection, medium was replaced with EpiCM with 0.5% FBS and DMEM high 
Glucose containing 5% FBS (S0115, Biochrom AG), respectively. For p62/SQSTM1 knock-
down experiments the SMARTpool siGENOME SQSTM1 siRNA (M-010230-00-0005, 
Dharmacon) and siGENOME Non-Targeting siRNA #2 (D-001210-02-05, Dharmacon) were 
transfected with Lipofectamine 3000 Reagent (L3000001, Thermo Fisher) according to 
manufacturer’s instructions, using 100 nM siRNA. 
 
• Electron microscopy 
Samples were rinsed with ice-cold cacodylate 0.1 M pH 7.4 and fixed with 2% 
paraformaldehyde, 2.5% glutaraldehyde (01909; Polysciences) in 0.1 M cacodylate pH 7.4. 
Samples were washed again with cacodylate buffer (0.1 M, pH 7.0 and postfixed in 1% 
osmium tetroxide and 1.5% potassium ferrocyanide in cacodylate buffer (0.1 M pH 7.4), 
followed by a 1% osmium in cacolylate buffer treatment. Sections were washed in distilled 
water. Samples were stained with 1% uracil acetate in water and rinsed once with H2O. 
Samples were de-hydrated in graded alcohol series and embedded in Epon. The images 
were taken with a TecnaiTm Spirit TEM (Fei, Thermo Fisher). Biopsy specimens were 
processed and analyzed as described previously (Drachenberg et al., 1999). 
 
• Immunofluorescence microscopy 
Microscopy was performed using an epifluorescence microscope (model eclipseE800; 
Nikon, Tokio, Japan) equipped with suitable filters and a digital camera (Hamamatsu, Tokio, 
Japan). The pictures were analyzed by Fiji (U.S. National Institutes of Health, Bethesda, 
MD) as described previously (Hirsch et al., 2016). 
 
• Confocal Laser Scanning Microscopy (CLSM) 
Confocal pictures were taken with a LeicaSP5 (Leica, Wetzlar, Germany) with a 63x Plan 
Apochromat/NA1.4 oil objective and pictures were further processed by Fiji. Z-stacks were 
acquired with a 63x Plan Apochromat/NA1.4 oil objective and the requirements of the 
Nyquist theorem were fulfilled, with voxel xyz size of 45, 45, 150 nm, respectively. To 
exclude the possibility of channel crosstalk, images were acquired sequentially using the 
multi-track mode. Deconvolution and visualization were done essentially as described in 
(Unterstab et al., 2010). For deconvolution, the Huygens professional software (Scientific 
Volume Imaging, Hilversum, the Netherlands) was used, applying the Classic Maximum 
Likelihood Estimation Mode (CMLE) using a theoretical point spread function (PSF) and 
IMARIS (Bitplane AG, Zurich, Switzerland) was used for visualization, colocalization 
analyzes, and quantification. 
 
• SDS/PAGE and immunoblotting  
Cells were lysed with RIPA buffer: 10 mM Tris/HCl pH 7.5; 150 mM NaCl; 0.5 mM EDTA. 
1.0% Nonidet P-40 and proteinase inhibitor (04693132001, Roche). Cell lysates were 
separated by Mini Protean TGX Gradient Gel 4-20% (4561095, Bio-Rad) and 
electrotransferred onto 0.45-μm Immobilon-FL polyvinylidene difluoride (PVDF) membrane 
(IPFL00010, Millipore/Merck). Membranes were blocked with Odyssey blocking buffer (927-
40000, LI-COR) diluted 1:2 in Tris-buffered saline (TBS). Primary and secondary antibodies 
were diluted in Odyssey blocking buffer diluted 1:2 in TBS-0.1% Tween 20 and incubated at 
RT for 1 h (or o/n at 4°C) or 45 min, respectively. Washing in between was performed with 
TBS–0.1% Tween 20. For the detection of p62/SQSTM1, cells were trypsinized and 2.0x104 
cells were resuspended and lysed per 10µL 1x Laemmli Sample Buffer (161-0747, Bio-Rad). 
10µL cell lysate was separated by SDS-PAGE, electrotransfered onto 0.2 µm Immobilon®-
PSQ PVDF membrane (ISEQ00010, Millipore/Merck) and immunoblotting was done 
essentially as described above, but 3.0% milk (T145.2, Roth) in TBS-0.1% Tween 20 was 
used instead of the Odyseey blocking buffer. Detection and quantification were done with 
the Odyssey CLx system (LI-COR, Lincoln, USA). 
 
• Enzyme-linked immunosorbent assays (ELISA)  
The ELISA was performed using the VeriKine-HsTM Human IFN Beta Serum ELISA KIT 
(41415, pbl assay science). The recommended enhanced protocol form improved 
performance in serum evolution was used. Samples were measured by Safire II plate reader 
in triplicates and the standard curve was generated using GraphPad Prism software (v8.1.0). 
 
• Immunohistochemistry 
After deparaffinization samples were heated for 30 min in the microwave at 98°C in citrate-
buffer (pH 6.0) and cooled down for 30 min. Samples were washed 15min with D-PBS and 
15 min in 10 mM D-PBS + 0.1% Tween20 (93773, Fluka). Samples were blocked with 5% 
normal goat serum (50197Z, Thermo Fisher), for 1 h at RT. Primary antibodies were diluted 
in 3% BSA/PBS (A9647, Sigma-Aldrich) and samples were incubated over night at 4°C 
followed by 25min washes in 10 mM PBS. Secondary antibodies were diluted in 3% 
BSA/PBS containing 1 µg/ml Hoechst 33342 (B2261, Sigma-Aldrich), followed by 25 min 
washes in 10 mM PBS. Samples were mounted with Prolong Gold (P36935, Thermo 
Fisher). 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
All results were analyzed by GraphPad Prism software (version 8.1.0). Level of significant 
variability between groups was tested as indicated in figure legends, using paired t-test or 
two-way analyses of variance (ANOVA), respectively. Significant differences were assumed 
for P values of <0.05. Unless indicated differently, groups were plotted as mean values and 
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